WallStreetZenWallStreetZen

NYSE: SNN
Smith & Nephew PLC Stock

Overview
ForecastEarningsDividendOwnership
$23.88-0.69 (-2.81%)
Updated Apr 25, 2024
SNN Price
$23.88
Fair Value Price
N/A
Market Cap
$10.48B
52 Week Low
$21.53
52 Week High
$33.09
P/E
39.54x
P/B
2.01x
P/S
2.16x
PEG
0.32x
Dividend Yield
3.14%
Revenue
$5.55B
Earnings
$263.00M
Gross Margin
68.8%
Operating Margin
7.6%
Profit Margin
4.7%
Debt to Equity
0.91
Operating Cash Flow
$608M
Beta
0.84
Next Earnings
May 2, 2024
Ex-Dividend
Apr 1, 2024
Next Dividend
May 22, 2024

SNN Overview

Smith & Nephew Public Limited Company is a medical technology company focused on medical devices for use in orthopaedic reconstruction and trauma, sports medicine, ENT and advanced wound management. The company offers knee and hip implants to replace diseased, damaged or worn joints; robotics-assisted enabling technologies; and trauma products to stabilize fractures and deformity correction procedures. Smith & Nephew was founded in 1856 and is headquartered in Watford, UK.

Zen Score

–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SNN scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

SNN ($23.88) is trading below its intrinsic value of $29.80, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SNN is good value based on its earnings relative to its share price (39.54x), compared to the US market average (40.97x)
P/E vs Market Valuation
SNN is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more SNN due diligence checks available for Premium users.

Be the first to know about important SNN news, forecast changes, insider trades & much more!

SNN News

Valuation

SNN price to earnings (PE)

For valuing profitable companies with steady earnings
Company
39.54x
Industry
29.73x
Market
40.97x
SNN is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
SNN is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

SNN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.01x
Industry
3.71x
SNN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

SNN price to earnings growth (PEG)

For valuing profitable companies with growth potential
SNN is good value based... subscribe to Premium to read more.
PEG Value Valuation

SNN's financial health

Profit margin

Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
SNN's Earnings (EBIT) of $422.00M... subscribe to Premium to read more.
Interest Coverage Financials
SNN's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$10.0B
Liabilities
$4.8B
Debt to equity
0.91
SNN's short-term assets ($4.03B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SNN's short-term assets ($4.03B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SNN's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
SNN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A
SNN's operating cash flow ($608.00M)... subscribe to Premium to read more.
Debt Coverage Financials

SNN vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
SNN$10.48B-2.81%39.54x2.01x
BRKR$11.09B-1.96%27.60x8.06x
PODD$11.48B-1.84%55.46x15.67x
SWAV$12.30B+0.04%82.04x18.40x
PEN$7.95B-0.32%86.71x6.75x
View Top Medical Device Stocks

Smith & Nephew Stock FAQ

What is Smith & Nephew's quote symbol?

(NYSE: SNN) Smith & Nephew trades on the NYSE under the ticker symbol SNN. Smith & Nephew stock quotes can also be displayed as NYSE: SNN.

If you're new to stock investing, here's how to buy Smith & Nephew stock.

What is the 52 week high and low for Smith & Nephew (NYSE: SNN)?

(NYSE: SNN) Smith & Nephew's 52-week high was $33.09, and its 52-week low was $21.53. It is currently -27.82% from its 52-week high and 10.94% from its 52-week low.

How much is Smith & Nephew stock worth today?

(NYSE: SNN) Smith & Nephew currently has 877,672,643 outstanding shares. With Smith & Nephew stock trading at $23.88 per share, the total value of Smith & Nephew stock (market capitalization) is $10.48B.

Smith & Nephew stock was originally listed at a price of $8.25 in Nov 16, 1999. If you had invested in Smith & Nephew stock at $8.25, your return over the last 24 years would have been 189.45%, for an annualized return of 4.53% (not including any dividends or dividend reinvestments).

How much is Smith & Nephew's stock price per share?

(NYSE: SNN) Smith & Nephew stock price per share is $23.88 today (as of Apr 25, 2024).

What is Smith & Nephew's Market Cap?

(NYSE: SNN) Smith & Nephew's market cap is $10.48B, as of Apr 26, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Smith & Nephew's market cap is calculated by multiplying SNN's current stock price of $23.88 by SNN's total outstanding shares of 877,672,643.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.